Biotronik has a full line of peripheral balloons .014,.018 and .035 as well as self expanding SFA and Iliac stents. There products were distributed the past two years by the vascular sales team at Getinge. The products are good but not really clinically superior to Medtronic, Boston, Abbott etc... They do have a tiny nich spot with their SFA stent in that it is the only SFA indicated stent available in a 4mm diameter.
The products were on all GPO contract through Getinge but will not be on contract when Biotronik sells direct. The peripheral Stent/Balloon market is very contract driven with Medtronic, Boston, Abbott controlling most of those contracts due to leverage with athrectomy etc....
Biotronik has a tiny (less than 5%, US) market share in CRM that coupled with the fact that vascular surgeons in most places are doing the bulk of peripheral work will not give Biotronik the a leg up in pull through products due to CRM presence
Personally what I see in peripherals is athrectomy/laser used in majority of cases with stents used as bailout, dissections etc..... Due to that Biotronik will have a tough time getting shelf space for stents and honestly balloons are becoming a commodity product bundled in with athrectomy etc... or going to the lowest bidder
